Injectable Semaglutide vs Dulaglutide in Individuals at Cardiovascular Risk

Clinical trial NCT07619495 · COMPLETED

Trial details

NCT number: NCT07619495
Sponsor: Brigham and Women's Hospital
Status: COMPLETED
Study type: OBSERVATIONAL

Type 2 Diabetes Mellitus Obesity Overweight

Start date: 2026-01-20
Primary completion: 2026-06-01
Enrollment: 120000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.